VEA vs EFA: returns, risk and drawdowns compared
Vanguard FTSE Developed Markets ETF against iShares MSCI EAFE ETF, over the same 6 years (July 2020 to November 2026) with dividends reinvested.
Data updated November 2026
VEA
Vanguard FTSE Developed Markets ETF
10,000 became
20,900
- A year on average
- +12.2%
- Annual volatility
- 15.9%
- Deepest fall
- −28.1%
- Worst month
- −9.9%
EFA
iShares MSCI EAFE ETF
10,000 became
19,958
- A year on average
- +11.4%
- Annual volatility
- 15.3%
- Deepest fall
- −27.6%
- Worst month
- −9.2%
VEA came out ahead by 0.8 percentage points a year from July 2020 to November 2026. VEA swung more (15.9% against 15.3% a year). The correlation of monthly returns was 0.99: they moved almost in lockstep.
Growth of 10,000: VEA vs EFA
Who was ahead, and when
The gap between the two over the previous three years, at each month-end. Above zero VEA had returned more, below zero EFA. VEA was ahead in 38% of the 42 three-year periods.
Annualised 3-year return of VEA minus that of EFA, in percentage points a year.
Falls from the previous high
Month-end values. Deepest fall: VEA −28.1%, EFA −27.6%.
All the figures
| VEA | EFA | |
|---|---|---|
| Annual return (CAGR) | +12.2% | +11.4% |
| Total return | +109% | +100% |
| Annual volatility | 15.9% | 15.3% |
| Deepest fall (month-end) | −28.1% | −27.6% |
| Worst month | −9.9% | −9.2% |
| Best month | +14.3% | +14.3% |
| Positive months | 60% | 62% |
| Best year | 2025: +35.2% | 2025: +31.6% |
| Worst year | 2022: −15.3% | 2022: −14.3% |
| 1-year return | +14.3% | +11.5% |
| 5 years, a year | +8.5% | +8.0% |
| 10 years, a year | — | +9.1% |
| Trading currency | USD | USD |
First nine rows: the same 77 months for both funds. Trailing returns: to each fund’s last close.
Year by year
Full calendar years both funds were trading. The higher of the two each year is in bold.
Holding both: half VEA, half EFA
| VEA alone | EFA alone | 50/50 | |
|---|---|---|---|
| A year on average | +12.2% | +11.4% | +11.8% |
| Annual volatility | 15.9% | 15.3% | 15.6% |
| Deepest fall (month-end) | −28.1% | −27.6% | −27.8% |
| Worst month | −9.9% | −9.2% | −9.5% |
With a correlation of 0.99 the mix behaved almost like either fund alone: its volatility of 15.6% sits between the two. Rebalanced to 50/50 every month, before costs.
Questions
Which has returned more, VEA or EFA?
From July 2020 to November 2026, VEA returned +12.2% a year and EFA +11.4% a year, with dividends reinvested. Over rolling 3-year periods VEA did better in 38% of cases. Past returns do not predict future returns.
Which is riskier, VEA or EFA?
Over the same months annual volatility was 15.9% for VEA and 15.3% for EFA; the deepest fall from a month-end high was 28.1% and 27.6%, and the worst single month −9.9% and −9.2%.
How correlated are VEA and EFA?
The correlation of their monthly returns was 0.99: they moved almost in lockstep. Holding both adds little diversification compared with holding one.
What about holding both VEA and EFA?
Half in each, rebalanced every month, returned +11.8% a year over the same period, with 15.6% annual volatility and a deepest month-end fall of 27.8%.
More comparisons
- VEA — Vanguard FTSE Developed Markets ETFReturns, drawdowns and risk
- EFA — iShares MSCI EAFE ETFReturns, drawdowns and risk
- VXUS vs VEA
- VEA vs IEFA
- VEA vs VWO
- VEA vs VGK
- VXUS vs EFA
- IEFA vs EFA
- Backtest a portfolio with rebalancing and costsRebalancing, costs and attribution
- Portfolio analytics software comparedFeatures and prices side by side
How the figures are calculated
Total return in the fund’s trading currency, from end-of-day prices with dividends reinvested on the ex-date. The fund’s own ongoing charges are already reflected in its price; trading costs, taxes and currency conversion are not included. Past returns do not predict future returns.
The comparison uses only the months in which both funds have prices, so the figures cover the same period even when one fund is older.
Source: MarketStack end-of-day prices, total return with dividends reinvested. Figures are historical and descriptive; they are not forecasts and not investment advice. MEDGE Capital does not recommend buying or selling any instrument. Risk disclaimer.